<code id='FEA154441E'></code><style id='FEA154441E'></style>
    • <acronym id='FEA154441E'></acronym>
      <center id='FEA154441E'><center id='FEA154441E'><tfoot id='FEA154441E'></tfoot></center><abbr id='FEA154441E'><dir id='FEA154441E'><tfoot id='FEA154441E'></tfoot><noframes id='FEA154441E'>

    • <optgroup id='FEA154441E'><strike id='FEA154441E'><sup id='FEA154441E'></sup></strike><code id='FEA154441E'></code></optgroup>
        1. <b id='FEA154441E'><label id='FEA154441E'><select id='FEA154441E'><dt id='FEA154441E'><span id='FEA154441E'></span></dt></select></label></b><u id='FEA154441E'></u>
          <i id='FEA154441E'><strike id='FEA154441E'><tt id='FEA154441E'><pre id='FEA154441E'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:2793
          Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC.
          Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

          WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

          Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

          advertisement

          The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Bird flu in dairy cattle: New measures to control spread to humans
          Bird flu in dairy cattle: New measures to control spread to humans

          FarmworkersmilkdairycowsinamilkingparlorinSchuylerville,N.Y.HansPennink/APWASHINGTON—Thefederalgover

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Insurer loopholes limit power of law against surprise medical bills

          AdobeYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followingtheflowofmoneyinmed